Stocktoria
Cabaletta Bio, Inc. CABA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-25
Cabaletta Bio, Inc. statistics & valuation
Market cap$495.7M
P / B4.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -101.7% | -62.6% | -26.7% | -45.3% | -36.6% |
| Return on equity | -149.8% | -76.1% | -28.7% | -50.7% | -39.2% |
| Current ratio | 2.77 | 6.15 | 15.29 | 11.47 | 14.86 |
Source: SEC EDGAR filings · CIK 0001759138 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.